Salivary histatin 3 inhibits heat shock cognate protein 70-mediated inflammatory cytokine production through toll-like receptors in human gingival fibroblasts

Abstract

BackgroundSalivary histatins are bioactive peptides related to the innate immune system associated with antimicrobial activities. However, very little is known about the physiological and biological functions of histatins against host cells or their role in oral cell inflammation. Histatin 3 binds to heat shock cognate protein 70 (HSC70, a constitutively expressed heat shock protein (HSP)). It is unclear whether HSC70 is involved in the inflammatory response in oral cells. Injured oral cells release some intracellular proteins including HSC70. It is possible that released HSC70 induces toll-like receptor (TLR) activation, just as extracellular HSP70 (a stress inducible HSP) does, and that histatin 3 affects this process. Therefore, we tested the hypothesis that HSC70 activates TLR signaling and histatin 3 inhibits this activation and inflammatory cytokine production.MethodsA nuclear factor (NF)-κB-dependent luciferase reporter plasmid was transfected into HEK293 cells stably expressing TLR2 with coreceptor CD14 (293-TLR2/CD14 cells) or stably expressing TLR4 with CD14 and the accessory molecule MD2 (293-TLR4/MD2-CD14 cells). The cells were stimulated with HSC70 in the presence or absence of histatin 3, and examined using luciferase assays. We also stimulated human gingival fibroblasts (HGFs) with HSC70 with or without histatin 3. Then, we analyzed the levels of inflammatory cytokines (interleukin (IL)-6 and IL-8) in the culture media. Cell proteins were analyzed using enzyme-linked immunosorbent assay and Western blotting with antibodies of mitogen-activated protein kinases and NF-κB inhibitor IκB-α, respectively. Histatin 3-bound form of HSC70 was analyzed using limited V8 protease proteolysis.ResultsHSC70 induced NF-κB activation in a dose-dependent manner in 293-TLR2/CD14 and 293-TLR4/MD2-CD14 cells, and histatin 3 inhibited this process and when histatin 3 binding to HSC70 was precluded by 15-deoxyspergualin, which augmented NF-κB-triggered activation. In HGFs, histatin 3 also inhibited HSC70-induced inflammatory cytokine production, extracellular signal-regulated protein kinase phosphorylation, and degradation of IκB-α. Moreover, HSC70 in the presence of histatin 3 was relatively resistant to digestion by V8 protease compared with HSC70 in the presence of control peptide.ConclusionsHistatin 3 may be an inhibitor of HSC70-triggered activation of TLR signaling and inflammatory cytokine production and may be involved in inflammation processes noted in oral cells.

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

“…31 This was accompanied by evidence of impaired innate local defenses with reduced histatins 1 and 5 and lysozyme. 32 This extends a study of increased fecal secretory IgA into saliva in cirrhosis and points to an overall activation of systemic inflammation, potentially through contributors in the gut and oral cavity. 33 Interestingly, whereas there clearly were differences in systemic inflammatory response in previous HE, compared to no-HE, we did not find similar changes in salivary inflammatory response between these subgroups.…”

Evaluation of Collagen Type-1 Production and Anti-Inflammatory Activities of Human Placental Extracts in Human Gingival Fibroblasts

“…The levels of collagen type I in the media were measured using the biotinylated anti-collagen type I antibody (0.2 g/ml). The ELISA procedure was performed as described in the user manual of the CytoSet kits (Biosource) 23) .…”

Recognition of Candida albicans by gingival fibroblasts: The role of TLR2, TLR4/CD14, and MyD88

“…TLR2 has been identified to activate cells in response to heat-shock protein 70 [33] and necrotic cells [32,34]. Recent reports have shown that HSC70 released from the damaged cells may stimulate human gingival fibroblasts (HGFs) [35,36]. Considering this information, our data suggest that DAMPs can directly activate gingival fibroblast via TLR-2 and regulated cell activation.…”